AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇸🇳
STAVUDINE in Senegal
8 products registered with ARP — 8 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| STAVIR comprimé / 40 mg | 4569 | CIPLA LTD | active | — |
| STAVIR comprimé / 30 mg | 4565 | CIPLA LTD | active | — |
| STAVUDINE AUROBINDO gélule / 30 mg | 5308 | AUROBINDO PHARMA LTD | active | — |
| AVOSTAV gélule / 30 mg | 4352 | RANBAXY LABORATOIRES LIMITED | active | — |
| STADINE gélule / 40 mg | 4705 | EMCURE PHARMACEUTICALS LTD | active | — |
| ZERIT gélule / 2O mg | 3747 | BRISTOL MYERS SQUIBB | active | — |
| STAVUDINE DE MACLEODS gélule / 30 mg | 5353 | MACLEODS PHARMACEUTICALS LTD | active | — |
| ZERIT gélule / 40 mg | 3749 | BRISTOL MYERS SQUIBB | active | — |
STAVUDINE — ARP Registration Details
ARP (Senegal) has 8 registered products containing STAVUDINE, of which 8 are currently active. Data is sourced directly from the official ARP drug register and refreshed daily.
Track STAVUDINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.